Promethera Biosciences Appoints Mutsuki Takano to Group Chief Financial Officer

Mont-Saint-Guibert, Belgium, October 5th, 2018 – Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced that Mutsuki Takano, currently Branch General Manager of Promethera Biosciences Japan Branch and Member of the Management Team of Promethera Biosciences SA will succeed Frank Hazevoets as Group Chief Financial Officer (Group CFO), in addition to his current responsibilities. 

Sign Up